ondansetron has been researched along with Hypospadias in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Hypospadias: A birth defect due to malformation of the URETHRA in which the urethral opening is below its normal location. In the male, the malformed urethra generally opens on the ventral surface of the PENIS or on the PERINEUM. In the female, the malformed urethral opening is in the VAGINA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belani, K | 1 |
Anderka, M | 1 |
Mitchell, AA | 1 |
Louik, C | 1 |
Werler, MM | 1 |
Hernández-Diaz, S | 1 |
Rasmussen, SA | 1 |
2 other studies available for ondansetron and Hypospadias
Article | Year |
---|---|
Postoperative nausea and vomiting in pediatric patients.
Topics: Adult; Antiemetics; Child; Circumcision, Male; Dexamethasone; Female; Humans; Hypospadias; Infant; M | 2011 |
Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.
Topics: Abnormalities, Drug-Induced; Adult; Case-Control Studies; Cleft Lip; Cleft Palate; Female; Humans; H | 2012 |